Immunic (IMUX) Cash from Operations (2013 - 2026)
Immunic (IMUX) posted Cash from Operations of 17301000.0 for Q1 2026, up 10.27% sequentially from 19281000.0 in Q4 2025, and up 20.55% YoY from 14351703.78 in Q1 2025.
Immunic (IMUX) Cash from Operations (2013 - 2026) Analysis & Trends
Immunic has reported Cash from Operations for 14 years, with the latest figure at 17301000.0 in Q1 2026.
- Quarterly Cash from Operations rose 20.55% year-over-year to 17301000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 81331000.0 (up 1.5% YoY) and the FY2025 annual result came in at 85806000.0, down 1.23% from the prior year.
- Cash from Operations advanced to 17301000.0 in Q1 2026 per IMUX's latest filing, from 19281000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 13596000.0 in Q3 2022 and troughed at 24609000.0 in Q2 2025.
- A 5-year average of 19049705.88 and a median of 19513000.0 in 2023 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2022 and 2024: Cash from Operations surged 45.65% in 2022, then plunged 63.71% in 2024.
- Over 5 years, Cash from Operations stood at 15104000.0 in 2022, then gained by 7.13% to 14027000.0 in 2023, then slumped by 63.71% to 22963000.0 in 2024, then rose by 16.03% to 19281000.0 in 2025, then rose by 10.27% to 17301000.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 17301000.0, 19281000.0, and 20140000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -387.32 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 462.82 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 728.46 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 326.72 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -88.83 Mn |
| 10 | Immunic | 682.77 Mn | 682.77 Mn | - | -31.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -31.00 Mn |
| Jun 30, 2026 | -31.00 Mn |
| Mar 31, 2026 | -17.30 Mn |
| Mar 31, 2026 | -17.30 Mn |
| Dec 31, 2025 | -19.28 Mn |
| Dec 31, 2025 | -19.28 Mn |
| Sep 30, 2025 | -20.14 Mn |
| Sep 30, 2025 | -20.14 Mn |
| Jun 30, 2025 | -24.61 Mn |
| Jun 30, 2025 | -24.61 Mn |
| Mar 31, 2025 | -21.78 Mn |
| Mar 31, 2025 | -21.78 Mn |
| Dec 31, 2024 | -22.96 Mn |
| Dec 31, 2024 | -22.96 Mn |
| Sep 30, 2024 | -20.80 Mn |
| Sep 30, 2024 | -20.80 Mn |
| Jun 30, 2024 | -17.04 Mn |
| Jun 30, 2024 | -17.04 Mn |
| Mar 31, 2024 | -23.97 Mn |
| Mar 31, 2024 | -23.97 Mn |